BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  TearLab Corporation to Release Q2-10 Financial Results on August 12, 2010

  August 4, 2010

   · 

  1 min read
• Business

  DexCom Reports Second Quarter 2010 Financial Results

  August 4, 2010

   · 

  1 min read
• Ambrilia Biopharma Inc. Provides Bi-Weekly Update on its Status

  August 4, 2010

   · 

  5 min read
• Drug Development

  GANYMED Pharmaceuticals AG Release: Clinical Phase I Results of GANYMED’s iMAB362 Antibody Demonstrate Excellent Safety

  August 4, 2010

   · 

  3 min read
• Business

  Sunesis Pharmaceuticals, Inc. Appoints Steering Committee and Clinical Partners for Vosaroxin Pivotal Phase 3 Trial in AML

  August 4, 2010

   · 

  7 min read
• Policy

  Teleflex Incorporated Announces Receipt of Additional Approvals of Certificates to Foreign Governments from FDA

  August 4, 2010

   · 

  1 min read
• Drug Development

  Cell Therapeutics, Inc. Files for Special Protocol Assessment (SPA) for Pixantrone in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma

  August 4, 2010

   · 

  4 min read
• Business

  Elusys Therapeutics, Inc. Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax

  August 4, 2010

   · 

  3 min read
• Business

  Watson Pharmaceuticals, Inc. Names Sigurdur Oli Olafsson Executive Vice President, Global Generics

  August 4, 2010

   · 

  4 min read
• Business

  Proximagen Neuroscience plc Signs Sale And Purchase Agreement For Sabcomeline

  August 4, 2010

   · 

  4 min read